Atlantic International Corp. (ATLN)
USD 5.68
(-3.89%)
USD 5.68
(-3.89%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -5.73 Million USD | -43.41% |
| 2022 | -3.99 Million USD | -56.84% |
| 2021 | -2.54 Million USD | -168.36% |
| 2020 | -949.72 Thousand USD | 58.55% |
| 2019 | -2.29 Million USD | 4.58% |
| 2018 | -2.4 Million USD | -57.24% |
| 2017 | -1.52 Million USD | -10.25% |
| 2016 | -1.38 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.06 Million USD | 14.14% |
| 2024 Q2 | -8.31 Million USD | -679.92% |
| 2023 Q1 | -1.75 Million USD | -41.14% |
| 2023 Q2 | -1.44 Million USD | 17.83% |
| 2023 Q4 | -1.24 Million USD | 3.69% |
| 2023 FY | -5.73 Million USD | -43.41% |
| 2023 Q3 | -1.28 Million USD | 10.76% |
| 2022 Q1 | -872.06 Thousand USD | 36.45% |
| 2022 Q3 | -918.5 Thousand USD | 4.43% |
| 2022 Q2 | -961.1 Thousand USD | -10.21% |
| 2022 FY | -3.99 Million USD | -56.84% |
| 2022 Q4 | -1.24 Million USD | -35.6% |
| 2021 Q4 | -1.37 Million USD | -239.03% |
| 2021 FY | -2.54 Million USD | -168.36% |
| 2021 Q3 | -404.75 Thousand USD | 0.0% |
| 2020 FY | -949.72 Thousand USD | 58.55% |
| 2019 FY | -2.29 Million USD | 4.58% |
| 2018 FY | -2.4 Million USD | -57.24% |
| 2017 FY | -1.52 Million USD | -10.25% |
| 2016 FY | -1.38 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -361.555% |
| Arrayit Corporation | -3.62 Million USD | -58.247% |
| Biocept, Inc. | -31.98 Million USD | 82.076% |
| Bioqual, Inc. | -19.63 Thousand USD | -29090.9% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -642.416% |
| DermTech, Inc. | -103.73 Million USD | 94.474% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.231% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 72.479% |
| iMD Companies, Inc. | -175.44 Thousand USD | -3167.392% |
| IDenta Corp. | -1499.00 USD | -382322.215% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 304.44% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 14916.513% |
| InVitro International | -25.33 Thousand USD | -22523.265% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 19.51% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -9764.587% |
| Medical Imaging Corp. | -819.48 Thousand USD | -599.53% |
| NovelStem International Corp. | -3.52 Million USD | -62.588% |
| Optigenex Inc. | 1.39 Million USD | 512.163% |
| PharmChem, Inc. | 973.14 Thousand USD | 689.069% |
| Proteome Sciences plc | -1.62 Million USD | -253.64% |
| Response Genetics, Inc | -21.37 Million USD | 73.184% |
| Rennova Health, Inc. | -1.4 Million USD | -306.695% |
| RushNet, Inc. | -684.7 Thousand USD | -737.223% |
| ScreenPro Security Inc. | -2.59 Million USD | -121.125% |
| Stella Diagnostics Inc. | -11.42 Million USD | 49.833% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 26.001% |
| Todos Medical Ltd. | -9.74 Million USD | 41.193% |